Decoding Idiopathic Intracranial Hypertension

Marc Bouffard discusses Mass General Brigham’s recently launched initiative aimed at better understanding idiopathic intracranial hypertension

1

The IIH Research and Treatment Initiative aims to improve diagnosis and treatment of idiopathic intracranial hypertension (IIH) through a multi-pronged approach.
2

DTI-ALPS is a noninvasive method that measures fluid flow changes in the glymphatic system, potentially aiding in the diagnosis of IIH.
3

Research indicates that glymphatic dysfunction may be a consequence of IIH rather than its cause, highlighting the need for better understanding of disease mechanisms.
4

ALPS-indices in IIH patients were found to cluster in subnormal and supranormal ranges, suggesting potential as a radiographic biomarker for diagnosis.
5

Ongoing studies aim to validate ALPS-indices as a diagnostic tool for IIH, with hopes of expanding sample sizes to enhance applicability.

1